No headlines found.
Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025
Globe Newswire (Mon, 12-Jan 9:00 AM ET)
Tevogen CEO Donates Personal Shares to Support Local Fire Department
Globe Newswire (Fri, 19-Dec 11:10 AM ET)
Globe Newswire (Thu, 11-Dec 3:15 PM ET)
Globe Newswire (Tue, 9-Dec 2:20 PM ET)
Tevogen Recognized on 2025 NJBIZ Power List Amid Growth and Multi-Billion-Dollar Revenue Outlook
Globe Newswire (Mon, 8-Dec 2:50 PM ET)
Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q
Globe Newswire (Fri, 14-Nov 2:32 PM ET)
Globe Newswire (Wed, 5-Nov 3:20 PM ET)
Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn
Globe Newswire (Mon, 3-Nov 2:45 PM ET)
Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress
Globe Newswire (Wed, 29-Oct 12:35 PM ET)
Tevogen Bio Holdings - Warrant trades on the stock market under the symbol TVGNW.
As of January 26, 2026, TVGNW stock price was flat at $0.04 with 29 million shares trading.
TVGNW has a beta of 0.85, meaning it tends to be less sensitive to market movements. TVGNW has a correlation of 0.03 to the broad based SPY ETF.
TVGNW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
TVGNW has underperformed the market in the last year with a price return of -46.4% while the SPY ETF gained +14.7%. TVGNW has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.6% and -7.5%, respectively, while the SPY returned +3.3% and -0.3%, respectively.
TVGNW support price is $.04 and resistance is $.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TVGNW shares will trade within this expected range on the day.
